ADVOCIN 180 Spain - English - HMA (Heads of Medicines Agencies)

advocin 180

pfizer limited - danofloxacin mesilate 180 mg/ml - solution for injection - cattle - danofloxacine

ADVOCIN 180 France - English - HMA (Heads of Medicines Agencies)

advocin 180

pfizer limited - danofloxacin mesilate 180 mg/ml - solution for injection - cattle - danofloxacine

ADVOCIN 180 Malta - English - HMA (Heads of Medicines Agencies)

advocin 180

pfizer limited - danofloxacin mesilate 180 mg/ml - solution for injection - cattle - danofloxacine

ADVOCIN 180 Romania - English - HMA (Heads of Medicines Agencies)

advocin 180

pfizer limited - danofloxacin mesilate 180 mg/ml - solution for injection - cattle - danofloxacine

ADVOCIN 180, 180 MG/ML, SOLUTION FOR INJECTION FOR CATTLE Ireland - English - HPRA (Health Products Regulatory Authority)

advocin 180, 180 mg/ml, solution for injection for cattle

zoetis ireland limited - danofloxacin - solution for injection - 180 mg/ml - danofloxacine - bovine - antibacterial

Orbax flavoured oral suspension 30 mg/ml for dogs and cats Ireland - English - HPRA (Health Products Regulatory Authority)

orbax flavoured oral suspension 30 mg/ml for dogs and cats

intervet ireland limited - orbifloxacin, micronised - oral suspension - 30 mg/ml - antibacterial - canine feline

Advocin 2.5% Solution for Injection United Kingdom - English - VMD (Veterinary Medicines Directorate)

advocin 2.5% solution for injection

zoetis uk limited - danofloxacin - solution for injection - antimicrobial - cattle, pigs

Orbax Flavoured Oral Suspension 30 mg/ml for Dogs and Cats United Kingdom - English - VMD (Veterinary Medicines Directorate)

orbax flavoured oral suspension 30 mg/ml for dogs and cats

msd animal health uk limited - orbifloxacin - oral suspension - antimicrobial - cats, dogs

Quofenix European Union - English - EMA (European Medicines Agency)

quofenix

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - community-acquired infections - antibacterials for systemic use, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.